|1|Diffuse Astrocytoma Initially Presenting as a Massive Intracerebral Hemorrhage: Case Report. (24418786)
Nozaki T.... Namba H.
|2|MET gain in diffuse astrocytomas is associated with poorer outcome. (22672415)
Pierscianek D.... Ohgaki H.
|3|DMBT1 homozygous deletion in diffuse astrocytomas is associated with unfavorable clinical outcome. (22805772)
Motomura K.... Ohgaki H.
|4|Clinicopathological features in the recurrence of oligodendroglioma and diffuse astrocytoma. (22648019)
Takeuchi H.... Kikuta K.
|5|A sensitive and specific diagnostic panel to distinguish diffuse astrocytoma from astrocytosis: chromosome 7 gain with mutant isocitrate dehydrogenase 1 and p53. (21343879)
Camelo-Piragua S.... Louis D.N.
|6|Delayed intracerebral radiation necrosis occurring a decade after conventional radiotherapy in a patient of diffuse astrocytoma. (21768679)
Banerjee A.D.... Bhagavatulla I.D.
|7|Focal cortical dysplasia coexisting with diffuse astrocytoma in childhood: a case report and reappraisal of the glial component in archival FCD cases. (21118400)
Masui K.... Iwaki T.
|8|Discrimination between low-grade oligodendrogliomas and diffuse astrocytoma with the aid of 11C-methionine positron emission tomography. (21214332)
Shinozaki N.... Iwadate Y.
|9|High frequency of IDH-1 mutation links glioneuronal tumors with neuropil-like islands to diffuse astrocytomas. (21755347)
Huse J.T.... Rosenblum M.K.
|10|Mutant IDH1-specific immunohistochemistry distinguishes diffuse astrocytoma from astrocytosis. (20044756)
Camelo-Piragua S.... Nutt C.L.
|11|Combined molecular analysis of BRAF and IDH1 distinguishes pilocytic astrocytoma from diffuse astrocytoma. (19543740)
Korshunov A.... Hartmann C.
|12|Akt/protein kinase B overexpression as an accurate prognostic marker in adult diffuse astrocytoma. (19240976)
Matsutani T.... Iwadate Y.
|13|ICAM-1 (Lys469Glu) and PECAM-1 (Leu125Val) polymorphisms in diffuse astrocytomas. (19306055)
Burim R.V.... Carlotti-JA_nior C.G.
|14|Pitfalls in the assessment of MGMT expression and in its correlation with survival in diffuse astrocytomas: proposal of a feasible immunohistochemical approach. (17965865)
Capper D.... Schittenhelm J.
|15|Tenascin-C expression relates to clinicopathological features in pilocytic and diffuse astrocytomas. (17983425)
Maris C.... Salmon I.
|16|Association of TP53 mutation, p53 overexpression, and p53 codon 72 polymorphism with susceptibility to apoptosis in adult patients with diffuse astrocytomas. (16711514)
Uno M.... Nagahashi-Marie S.K.
|17|Exploring the distinctive biological characteristics of pilocytic and low-grade diffuse astrocytomas using microarray gene expression profiles. (16896313)
Rorive S.... Decaestecker C.
|18|Detection of somatic TP53 splice site mutations in diffuse astrocytomas. (15914282)
Uno M.... Nagahashi Marie S.K.
|19|Localization of the endothelin system in human diffuse astrocytomas. (16007684)
Naidoo V.... Raidoo D.M.
|20|Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomas. (15118874)
Okamoto Y.... Ohgaki H.
|21|Galectin-3 as an immunohistochemical tool to distinguish pilocytic astrocytomas from diffuse astrocytomas, and glioblastomas from anaplastic oligodendrogliomas. (15605987)
Neder L.... Zago M.A.
|22|Deregulation of the TP53/p14ARF tumor suppressor pathway in low-grade diffuse astrocytomas and its influence on clinical course. (14581362)
Watanabe T.... Yokoyama T.
|23|Promoter hypermethylation of the DNA repair gene O6-methylguanine-DNA methyltransferase is an independent predictor of shortened progression free survival in patients with low-grade diffuse astrocytomas. (12744471)
Komine C.... Fukushima T.
|24|Morphological changes and stress responses in neurons in cerebral cortex infiltrated by diffuse astrocytoma. (14719540)
Goel S.... Whittle I.R.
|25|Treatment of low-grade diffuse astrocytomas by surgery and human fibroblast interferon without radiation therapy. (12622456)
Watanabe T.... Fukushima T.
|26|Evaluation of molecular markers in low-grade diffuse astrocytomas: loss of p16 and retinoblastoma protein expression is associated with short survival. (11914625)
Hilton D.A.... Love S.
|27|Phenotype versus genotype correlation in oligodendrogliomas and low-grade diffuse astrocytomas. (11907807)
Watanabe T.... Ohgaki H.
|28|Microtubule-associated protein 2 (MAP-2) is expressed in low and high grade diffuse astrocytomas. (11922706)
Wharton S.B.... Whittle I.R.
|29|Mitosin and DNA topoisomerase IIalpha: two novel proliferation markers in the prognostication of diffuse astrocytoma patient survival. (11556747)
Korkolopoulou P.... Davaris P.
|30|Differentiation between reactive gliosis and diffuse astrocytoma by in situ hybridization. (11342694)
Wessels P.H.... Twijnstra A.
|31|Pilocytic astrocytomas do not show most of the genetic changes commonly seen in diffuse astrocytomas. (11119125)
Cheng Y.... Poon W.S.
|32|Gene expression profiling of low-grade diffuse astrocytomas by cDNA arrays. (11156382)
Huang H.... Ohgaki H.
|33|Genetic heterogeneity and progression in different areas within high-grade diffuse astrocytoma. (10601603)
Shuangshoti S.... Mutirangura A.
|34|Phase II study of ifosfamide with mesna in adult patients with recurrent diffuse astrocytoma. (1902506)
Elliott T.E.... Scheithauer B.W.
|35|Correlation of computed tomography and postmortem findings of a diffuse astrocytoma: a case report. (2598161)
Carter D.J.... Ho K.C.